• Customer Login
  • Search
KindredBio
  • About
    • Background
    • KindredBio Leadership
    • Board of Directors
  • Pipeline
    • Canine Pipeline
    • Clinical Trials
  • Products
    • Zimeta™ (dipyrone injection)
  • Technology
    • Veterinary Recombinant Biologics
    • Manufacturing Process
  • Education
    • Continuing Education
    • KINections
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Stock Information
    • Financial Information
    • Investor Resources
  • News
    • Press Releases
  • Contact Us
    • Contact Us
    • Careers
  • Menu

login

You are here: Home / login
Username
Password

» Lost your Password?

News

  • Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic DermatitisDecember 22, 2020 - 8:40 am
  • Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel DiseaseDecember 21, 2020 - 8:39 am
  • Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal AntibodyDecember 11, 2020 - 8:04 am

Events

  • Event: Kindred Biosciences to Present at Stifel 2020 Virtual Healthcare ConferenceNovember 11, 2020 - 8:38 am
  • Event: Kindred Biosciences to Participate in A.G.P. Virtual Healthcare SymposiumNovember 11, 2020 - 8:37 am
  • Event: Kindred Biosciences to Announce Third Quarter 2020 Financial ResultsOctober 28, 2020 - 4:10 pm
$4.43 Stock is Down -0.02 (-0.45%)
KIN (Common Stock)
Previous Close Volume
$4.45 45,959
Intraday High Intraday Low
$4.49 $4.34
52 Week High 52 Week Low
$11.93 $3.10
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top